A detailed history of Ra Capital Management, L.P. transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 14,932,063 shares of ABOS stock, worth $35.4 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
14,932,063
Previous 14,932,063 -0.0%
Holding current value
$35.4 Million
Previous $36.1 Million 2.48%
% of portfolio
0.52%
Previous 0.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.14 - $4.01 $32 Million - $59.9 Million
14,932,063 New
14,932,063 $36.1 Million
Q4 2023

Feb 14, 2024

BUY
$1.86 - $4.48 $27.8 Million - $66.9 Million
14,932,063 New
14,932,063 $57.3 Million
Q3 2023

Nov 14, 2023

BUY
$4.15 - $9.72 $21.4 Million - $50.2 Million
5,161,290 Added 52.82%
14,932,063 $62 Million
Q3 2021

Nov 15, 2021

BUY
$14.5 - $20.28 $142 Million - $198 Million
9,770,773 New
9,770,773 $145 Million

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $96M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.